Índice Bovespa

US Dollar vs BRL

Cadastre-se para alertas em tempo real, use o simulador personalizado e observe os movimentos do mercado.

Cadastre-se

MRK Merck and Co Inc

125,40

0,17 (0,14%)

19 Abr 2024 - Fechado

Atrasado em 15 minutos

Estados Unidos: Índice Dow Jones fecha em alta de +0,67% nesta sexta-feira, 23 de abril de 2021

/jornal/2021/04/estados-unidos-indice-dow-jones-fecha-em-alta-de-0-67-nesta-sexta-feira-23-de-abril-de-2021/

Merck (NYSE:MRK)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024

Click aqui para mais gráficos Merck.

Merck (NYSE:MRK)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024

Click aqui para mais gráficos Merck.

Notícias

Santé Canada approuve KEYTRUDA® comme traitement de première intention, en association avec une chimiothérapie à base de fluoropyrimidine et de platine, des adultes atteints d'un adénocarcinome gastrique ou de la jonction gastro-œsophagienne (JGO) H
Sexta, 19 de Abril de 2024 (1 dia atrás) • PR Newswire (Canada)

Delta Generates US$37 Million Profit in Q1, Google and Intel Unveil Cutting-Edge AI Chips, and More News
Quarta, 10 de Abril de 2024 (1 semana atrás) • IH Market News

Merck Initiates Phase 3 Clinical Trial of MK-1084, an Investigational Oral KRAS G12C Inhibitor, in Combination with KEYTRUDA® (pembrolizumab) for First-Line Treatment of Certain Patients With Metastatic Non-Small Cell Lung Cancer
Quinta, 4 de Abril de 2024 (2 semanas atrás) • Business Wire

REJOICE-Ovarian01 Phase 2/3 Trial of Raludotatug Deruxtecan Initiated in Patients with Platinum-Resistant Ovarian Cancer
Quarta, 3 de Abril de 2024 (2 semanas atrás) • Business Wire

Merck to Hold First-Quarter 2024 Sales and Earnings Conference Call April 25
Segunda, 1 de Abril de 2024 (3 semanas atrás) • Business Wire

European Commission Approves Merck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy as Neoadjuvant Treatment, Then Continued as Monotherapy as Adjuvant Treatment, for Resectable Non-Small Cell Lung Cancer (NSCLC) at High Risk of Recurrence in Adults
Quinta, 28 de Março de 2024 (3 semanas atrás) • Business Wire

GameStop Shares Tumble 20% in Pre-Market Trading Amid Revenue Decline, Direct Digital Plummets 42%, and More News
Quarta, 27 de Março de 2024 (3 semanas atrás) • IH Market News

FDA Approves Merck’s WINREVAIR™ (sotatercept-csrk), a First-in-Class Treatment for Adults with Pulmonary Arterial Hypertension (PAH, WHO* Group 1)
Terça, 26 de Março de 2024 (4 semanas atrás) • Business Wire

Merck Provides Update on Phase 3 KEYLYNK-006 Trial Evaluating KEYTRUDA® (pembrolizumab) Plus Maintenance LYNPARZA® (olaparib) for Certain Patients With Metastatic Nonsquamous Non-Small Cell Lung Cancer
Quinta, 21 de Março de 2024 (1 mês atrás) • Business Wire

Merck Announces Positive Data on V116, an Investigational, 21-Valent Pneumococcal Conjugate Vaccine Specifically Designed for Adults, Demonstrated Immune Responses in Adults
Terça, 19 de Março de 2024 (1 mês atrás) • Business Wire

FarmSee Ltd Announces the Completion of a Minority Investment in its Swine Monitoring Platform
Sexta, 15 de Março de 2024 (1 mês atrás) • PR Newswire (US)

Merck’s KEYTRUDA® (pembrolizumab) Plus Chemoradiotherapy (CRT) Significantly Improved Overall Survival (OS) Versus CRT Alone in Patients With Newly Diagnosed High-Risk Locally Advanced Cervical Cancer
Sexta, 15 de Março de 2024 (1 mês atrás) • Business Wire

Mais Notícias de

Índice Bovespa

Grupo Casas Bahia ON

MAGAZINE LUIZA ON

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições